银杏黄酮苷与复方丹参片治疗冠心病心绞痛疗效比较  

A Comparison of Effects of Ginkgo Biloba Flavonal Glyco and Compound Salvia Miltiorrhiza Tablets in Treating Patients with Angina

作　　者：陈静[1] 许喜泳[1] 刘淑华[2] 

机构地区：[1]武汉大学中南医院急诊科,430071 [2]武汉大学人民医院综合医疗科,430060

出　　处：《医药导报》2004年第1期23-25,共3页Herald of Medicine

摘　　要：目的 :比较银杏黄酮苷 (舒血宁片 )与复方丹参片治疗冠心病心绞痛的疗效。方法 :68例冠心病心绞痛患者随机分为 ,治疗组 3 8例 ,口服银杏黄酮苷 2片 ,tid ;对照组 3 0例 ,口服复方丹参片 3片 ,tid。两组疗程均为 4周 ,治疗前后观察临床症状、心电图、心功能、血液流变学、硝酸甘油用量及不良反应。结果 :治疗组在临床症状及心电图、心功能及血液流变学的改善、硝酸甘油停减率方面均优于对照组 (P <0 .0 5 ) ,无明显不良反应。结论 :银杏黄酮苷治疗心绞痛安全有效 ,优于复方丹参片。Objective:To compare the therapeutic effects of ginkgo biloba flavonal glyco and compound salvia miltiorrhiza tablets in treating patients with angina. Method:68 patients were divided randomly into study group(n=38, ginkgo biloba flavonal glyco, 2 tablets, tid, po) and control group(n=30, compound salvia miltiorrhiza, 3 tablets, tid, po). Before and 4 weeks after the treatment, the clinical symptoms, electrocardiograms, cardiac functions, hemorheology, dosage of nitroglycerin and the adverse effects were observed. Results:The study group had better therapeutic effects in improving clinical symptoms(P<0.05), electrocardiograms, cardiac functions and hemorheology(P<0.05); and needed a smaller dosage of nitroglycerin than the control group(P<0.05). There were no obvious adverse effects in both groups. Conclusion:Ginkgo biloba flavonal glyco is safe and efficient in the therapy of patients with angina and it is superior to compound salvia miltiorrhiza.

关 键 词：银杏黄酮苷 丹参片 复方 心绞痛 

分 类 号：R286[医药卫生—中药学] R541.4[医药卫生—中医学]